X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- X4 Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 186.3M, a 741.08% increase year-over-year.
- X4 Pharmaceuticals Inc. shareholder equity for 2025 were 186.3M, a 741.08% increase from 2024.
- X4 Pharmaceuticals Inc. shareholder equity for 2024 were 22.1M, a 56.65% decrease from 2023.
- X4 Pharmaceuticals Inc. shareholder equity for 2023 were 51.1M, a 30.99% decrease from 2022.
- X4 Pharmaceuticals Inc. shareholder equity for 2022 were 74.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| X4 Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $186 |
| 2024 | $22 |
| 2023 | $51 |
| 2022 | $74 |
| 2021 | $64 |
| 2020 | $73 |
| 2019 | $129 |
| 2018 | $-77 |
| X4 Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $186 |
| 2024-12-31 | $22 |
| 2023-12-31 | $51 |
| 2022-12-31 | $74 |
| 2021-12-31 | $64 |
| 2020-12-31 | $73 |
| 2019-12-31 | $129 |
| 2018-12-31 | $-77 |
X4 Pharmaceuticals Inc. Shareholder Equity — FAQ
X4 Pharmaceuticals Inc. (XFOR) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XFOR's shareholder equity history?
The chart and table above show X4 Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.